Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Molecular Medicine (Cambridge, Mass.)|April 5, 2013
Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostatSilvia Consalvi, Chiara Mozzetta, Paolo Bettica, et al.Biopolymers|September 10, 2004
The Mycobacterium tuberculosis chaperonin 10 monomer exhibits structural plasticityGianluca Fossati, Pietro Cremonesi, Gaetano Izzo, et al.Molecular Medicine (Cambridge, Mass.)|March 25, 2006
The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivoFlavio Leoni, Gianluca Fossati, Eli C Lewis, et al.Arthritis Research & Therapy|July 22, 2018
Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulationChiara Angiolilli, Pawel A Kabala, Aleksander M Grabiec, et al.The Journal of Clinical Investigation|June 24, 2008
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in micePavan Reddy, Yaping Sun, Tomomi Toubai, et al.Journal of Cancer Research and Clinical Oncology|November 27, 2018
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastomaFrancesco Marampon, Flavio Leoni, Andrea Mancini, et al.Journal of Cancer Research and Clinical Oncology|July 27, 2019
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastomaFrancesco Marampon, Flavio Leoni, Andrea Mancini, et al.Annals of the Rheumatic Diseases|July 27, 2016
Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytesChiara Angiolilli, Pawel A Kabala, Aleksander M Grabiec, et al.Science Translational Medicine|February 14, 2018
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanismMark Y Jeong, Ying H Lin, Sara A Wennersten, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokinesFlavio Leoni, Andrea Zaliani, Giorgio Bertolini, et al.Pageof 5